Exosens Forecast, price target & analysts
Exosens Target price 2026 - Analyst rating & recommendation
Exosens Classifications & Recommendation
Exosens Price Target
| Target Price | €70.38 |
| Price | €58.40 |
| Potential |
20.51%
register free of charge
|
| Number of Estimates | 14 |
|
14 Analysts have issued a price target Exosens 2027 .
The average Exosens target price is €70.38.
This is
20.51%
register free of charge
€78.75
34.85%
register free of charge
€63.63
8.96%
register free of charge
|
|
| A rating was issued by 19 analysts: 15 Analysts recommend Exosens to buy, 4 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Exosens stock has an average upside potential 2027 of
20.51%
register free of charge
|
Sales and Margin forecast 2026, 2027 to 2033
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Million € | 468.19 | 555.37 |
| 22.10% | 18.62% | |
| EBITDA Margin | 30.98% | 33.66% |
| 11.11% | 8.65% |
14 Analysts have issued a sales forecast Exosens 2026 . The average Exosens sales estimate is
This results in the following potential growth metrics:
14 Analysts have issued an Exosens EBITDA forecast 2026. The average Exosens EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2033
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share € | 0.84 | 1.83 |
| 15.07% | 117.86% | |
| P/E | 31.98 | |
| EV/Sales | 5.40 |
14 Analysts have issued a Exosens forecast for earnings per share. The average Exosens EPS is
This results in the following potential growth metrics and future valuations:
Current Exosens Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| BNP PARIBAS |
Locked
➜
Locked
|
Locked | Sep 22 2026 |
| BERENBERG |
Locked
➜
Locked
|
Locked | Sep 21 2026 |
| MAREX |
Locked
➜
Locked
|
Locked | Sep 18 2026 |
| ODDO BHF |
Locked
➜
Locked
|
Locked | Sep 18 2026 |
| TP ICAP |
Locked
➜
Locked
|
Locked | Sep 17 2026 |
| STIFEL EUROPE |
Locked
➜
Locked
|
Locked | Sep 17 2026 |
| ODDO BHF |
Locked
➜
Locked
|
Locked | Jul 13 2026 |
| Analyst Rating | Date |
|---|---|
|
Locked
BNP PARIBAS:
Locked
➜
Locked
|
Sep 22 2026 |
|
Locked
BERENBERG:
Locked
➜
Locked
|
Sep 21 2026 |
|
Locked
MAREX:
Locked
➜
Locked
|
Sep 18 2026 |
|
Locked
ODDO BHF:
Locked
➜
Locked
|
Sep 18 2026 |
|
Locked
TP ICAP:
Locked
➜
Locked
|
Sep 17 2026 |
|
Locked
STIFEL EUROPE:
Locked
➜
Locked
|
Sep 17 2026 |
|
Locked
ODDO BHF:
Locked
➜
Locked
|
Jul 13 2026 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
